US Broker Ratings

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Unpacking a Biotech with 26% Upside Potential

PTC Therapeutics, Inc. (NASDAQ: PTCT), a leader in the biotechnology sector, stands out with its strong focus on developing treatments for rare disorders. With a market capitalization of $3.87 billion,..

Twist Bioscience Corporation (TWST)

⚠️ No article content returned.

..

AtriCure, Inc. (ATRC) Stock Analysis: Strong Buy Ratings and 46.73% Potential Upside in Healthcare Sector

AtriCure, Inc. (NASDAQ: ATRC), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, continues to draw significant investor attention with its innovative surgical solutions...

Travere Therapeutics, Inc. (TVTX) Investor Outlook: Exploring a Potential 124% Upside in the Biotech Sector

Travere Therapeutics, Inc. (TVTX), a prominent player in the biotechnology industry, is capturing investor attention with its remarkable growth potential. Based in San Diego, California, this biopharmaceutical company focuses on..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: 83% Potential Upside Ignites Investor Interest

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a prominent player in the biotech industry, is capturing significant attention from investors, thanks to its impressive potential upside of 83.31%. With a market capitalization..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Exploring the 17.49% Potential Upside in Medicare-Centric Healthcare

Alignment Healthcare, Inc. (NASDAQ: ALHC) has garnered the attention of investors in the healthcare industry with its innovative approach to providing consumer-centric healthcare services, particularly for seniors through its Medicare..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 46.75% Potential Upside

Vericel Corporation (NASDAQ: VCEL) is drawing considerable attention in the biotechnology sector, not just for its innovative contributions to healthcare but also for its promising investment potential. With a market..

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: A Biotech Powerhouse with 36.55% Upside Potential

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is making waves in the biotechnology sector, offering intriguing prospects for investors interested in the healthcare industry. Headquartered in Coral Gables, Florida, this biopharmaceutical company..

CONMED Corporation (CNMD) Stock Analysis: Exploring an 18.57% Potential Upside in the Medical Device Sector

CONMED Corporation (NASDAQ: CNMD) stands as a notable player within the healthcare sector, particularly in the medical devices industry. With a market capitalization of $1.71 billion, this U.S.-based company is..

Premier, Inc. (PINC) Stock Analysis: Navigating the Healthcare Information Services Landscape with a 3.67% Dividend Yield

Premier, Inc. (NASDAQ: PINC) operates at the crossroads of healthcare improvement and technological innovation, providing services that aim to enhance the performance of healthcare providers across the United States. With..

Concentra Group Holdings Parent (CON) Stock Analysis: A Healthy 30.29% Potential Upside Awaits Investors

Concentra Group Holdings Parent, Inc. (CON), a key player in the healthcare sector, specifically within the medical care facilities industry, has been drawing attention from investors due to its promising..

Perrigo Company plc (PRGO): Investor Outlook with 36.65% Potential Upside

Perrigo Company plc (NYSE: PRGO), a key player in the healthcare sector, is capturing investor interest with its substantial potential upside of 36.65%, according to the latest analyst ratings. Based..

UFP Technologies, Inc. (UFPT) Investor Outlook: A 33.94% Potential Upside in the Healthcare Sector

UFP Technologies, Inc. (UFPT) stands at the forefront of innovation in the healthcare sector, specifically in the realm of medical devices. With its headquarters in Newburyport, Massachusetts, this American company..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: Exploring a 158% Upside Potential in Biotechnology

Apogee Therapeutics, Inc. (NASDAQ: APGE), a clinical-stage biotechnology company, has captured the attention of investors with its innovative approach to treating a range of inflammatory and immunology conditions. Headquartered in..

Sotera Health Company (SHC) Stock Analysis: A Look into Its 24.22% Potential Upside

Sotera Health Company (NASDAQ: SHC) is a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry. Headquartered in Broadview Heights, Ohio, the company operates on a..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: Potential Upside of 156.79% Draws Investor Attention

Amicus Therapeutics, Inc. (NASDAQ: FOLD), a pioneering entity in the biotechnology sector, has recently captured the spotlight among investors due to its substantial potential upside. This New Jersey-based company specializes..

Alphatec Holdings (ATEC) Stock Analysis: Navigating a 48.93% Potential Upside Amid Robust Revenue Growth

Alphatec Holdings, Inc. (NASDAQ: ATEC), a burgeoning player in the healthcare sector, is capturing the attention of investors, not just for its innovative spinal disorder treatments, but also for its..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Exploring a 21.59% Potential Upside in the CNS Treatment Market

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a biopharmaceutical company headquartered in Rockville, Maryland, is strategically positioned in the healthcare sector, specifically within the realm of specialty and generic drug manufacturing. With..

Select Medical Holdings Corp (SEM): Investor Outlook Reveals 35.40% Upside Potential

Select Medical Holdings Corporation (NYSE: SEM) stands as a notable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $1.95 billion, the..

Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 51% Upside Potential with Strong Buy Ratings

Veracyte, Inc. (NASDAQ: VCYT), a prominent player in the healthcare sector, specifically in the diagnostics and research industry, is capturing investor attention with its promising growth trajectory and robust analyst..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds